NCT04396353

Brief Summary

The present study aims to assess the impact of exercise training, physical activity, and sedentary lifestyle on clinical outcomes in surviving patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therefore, this study will evaluate cross-sectionally and through a questionnaire in Portuguese and English on the internet, whether physically active patients have better outcomes for the disease such as shorter hospital stay, lesser symptoms, lesser need for mechanical ventilation, and medications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,574

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 20, 2020

Completed
15 days until next milestone

Study Start

First participant enrolled

June 4, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
Last Updated

October 22, 2020

Status Verified

May 1, 2020

Enrollment Period

4 months

First QC Date

May 18, 2020

Last Update Submit

October 21, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of hospitalizations

    Number of hospitalizations required due to COVID-19

    Up to 6 months after hospital discharge and/or full recovery from the disease (asymptomatic)

Secondary Outcomes (3)

  • Percentage of symptoms of the disease

    Up to 6 months after hospital discharge and/or full recovery from the disease (asymptomatic)

  • Length of hospital stay

    Up to 6 months after hospital discharge and/or full recovery from the disease (asymptomatic)

  • Percentage of mechanical ventilation

    Up to 6 months after hospital discharge and/or full recovery from the disease (asymptomatic)

Study Arms (2)

Physically active

Those who receive regular amounts of physical activity. Those who participate in a minimum of 150 minutes of moderate exercise, or 75 minutes of a more vigorous regimen as recommended by the health organizations. Additionally, a person who spend less time sitting (i.e. watching television, surfing the web, playing video games).

Other: Electronic questionnaire

Sedentary

Those who do not receive regular amounts of physical activity. Where physical inactivity is considered the failure to meet the recommendations of the health organizations, stating that an individual should participate in a minimum of 150 minutes of moderate exercise, or 75 minutes of a more vigorous regimen. Sitting about 70-85% of the time (i.e. watching television, surfing the web, playing video games) is also considered a person living a sedentary lifestyle.

Other: Electronic questionnaire

Interventions

Clinical, anthropometric, and sociodemographic variables to characterize the sample will be collected using the Google Form. The same tool will be used to collect clinical variables (outcomes), as well as to obtain data on the level of physical activity and sedentary behavior time (predictor variables) prior to SARS-CoV-2 contamination. For this, we will use the International Physical Activity Questionnaire (IPAQ).

Physically activeSedentary

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Surviving patients infected with SARS-CoV-2, as confirmed by a reverse transcription-polymerase chain reaction (RT-PCR) test, blood test (serology), and a rapid antibody test in Brazil and worldwide, will be considered eligible for the study. Only those patients fully recovered from the disease and asymptomatic will be included.

You may qualify if:

  • Men and women recovered and survivors of the disease
  • With or without symptoms
  • Patients with disease confirmation by reverse transcription-polymerase chain reaction (RT-PCR) test, blood test (serology), and a rapid antibody test
  • With or without the need for hospitalization (nursery, semi-intensive and intensive unit)
  • With or without the need for drug treatment
  • Presence of any chronic disease such as diabetes, hypertension, coronary artery disease, obesity, metabolic syndrome, cancer, among others
  • Literate patients in Portuguese and/or English.

You may not qualify if:

  • Illiterate patients with difficulties in filling out the electronic form
  • Patients still hospitalized and/or with symptoms of COVID-19

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marcelo Rodrigues dos Santos

São Paulo, São Paulo, 05403-900, Brazil

Location

MeSH Terms

Conditions

COVID-19Coronavirus InfectionsSedentary Behavior

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesBehavior

Study Officials

  • Marcelo R Santos, PhD

    University of Sao Paulo Medical School

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 18, 2020

First Posted

May 20, 2020

Study Start

June 4, 2020

Primary Completion

October 1, 2020

Study Completion

October 1, 2020

Last Updated

October 22, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will share

All data will be shared publicly through the tool Open Science Framework.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
Starting in June 2020. All the data will be available permanently.
Access Criteria
Data will be available to other researchers after the end of the study. Data will be available for statistical analyses. The personal data of volunteers will not be identified. The principal investigator will be responsible for requests and criteria for information that will be shared.
More information

Locations